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Abstract 
Background. Huntington’s disease (HD) results in a range of cognitive and motor impairments 
that progress throughout the disease stages; however, little research has evaluated specific dual-
task abilities in this population, and the degree to which they may be related to functional ability.  
Objectives. The purpose of this study was to a) examine simple and complex motor-cognitive 
dual-task performance in individuals with HD, b) determine relationships between dual-task 
walking ability and disease-specific measures of motor, cognitive and functional ability, and c) 
examine the relationship of dual-task measures to falls in individuals with HD.  Methods. Thirty-
two individuals with Huntington’s disease were evaluated for simple and complex dual-task 
ability using the Walking While Talking Test. Demographics and disease-specific measures of 
motor, cognitive and functional ability were also obtained. Results. Individuals with HD had 
impairments in simple and complex dual-task ability. Simple dual-task walking was correlated to 
disease-specific motor scores as well as cognitive performance, but complex dual-task walking 
was correlated with total functional capacity, as well as a range of cognitive measures. Number 
of prospective falls was strongly correlated to dual-task measures.  Conclusions. Our results 
suggest that individuals with HD have impairments in cognitive-motor dual-task ability that are 
related to disease progression and specifically functional ability. Dual-task measures appear to 
evaluate a unique construct in individuals with early to mid-stage HD, and may have value in 
improving the prediction of falls risk in this population. 
 
Keywords. Huntington’s disease, dual-task, motor, cognitive, falls  
 
  
3 
 
Introduction 
Individuals with HD typically present with a range of motor impairments, including 
akinesia, bradykinesia, and incoordination[1] that progress over time and affect functional 
ability. Declines in cognition are a notable feature of the disease process, and people with HD 
often have difficulty holding, shifting[2] and dividing attention[3]. Difficulty with divided 
attention, or simultaneously monitoring two tasks, is particularly significant given that 
automaticity can change with damage to the nervous system; previously automatic movements, 
such as walking or balancing in standing may become attention demanding[4] and place an 
increased load on cognitive resources.  
Impairments in simultaneous motor-cognitive tasks, i.e. dual-tasks, have been well 
documented in neurodegenerative disease populations, including Parkinson’s disease (PD)[5], 
Alzheimer’s disease[6] and Multiple Sclerosis[7]. In HD, prior studies have shown impairments 
while performing complex cognitive dual-tasks (competing cognitive tasks with a manual or 
vocal response)[8] and automaticity with bi-manual tapping tasks (motor-motor dual-task)[9], 
particularly as task difficulty increases. Guidelines to increase task complexity have not been 
established; while some have utilized decision-making as the added complexity[10], studies in 
other populations have utilized inhibitory control of speech[11] to probe executive functioning 
and task-switching control under dual-task conditions. Although early work demonstrated no 
relationship among cognitive performance and walking[12], recent work showed that gait speed 
during motor-cognitive dual-task walking (i.e., walking with backward counting) has been linked 
with United Huntington’s Disease Rating Scale Total Motor Score (UHDRS-TMS) and 
performance on cognitive testing[13]. Individuals with greater cognitive impairment also 
demonstrate greater dual-task interference for complex cognitive tasks[10]. Although individuals 
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with HD can modify their walking speed in response to external cues[12,14], this ability declines 
with increasing gait impairment, and the impact of cognitive status on this relationship has not 
been determined.  
Individuals with HD commonly experience falls[15]; in one prospective study, 21% of 
participants experienced 1 fall and 58% experienced at least 2 falls over the course of a year[15]. 
Difficulty performing dual-tasks has been associated with falls in people with PD[16] and 
multiple sclerosis[7].  Falls in HD have been linked with slower walking speed and poorer 
balance[15], but their relationship with dual-task performance has not been evaluated. 
The purpose of this study was to a) examine simple and complex motor-cognitive dual-
task performance in individuals with HD, b) determine relationships between dual-task walking 
ability and disease-specific measures of motor, cognitive and functional ability, and c) examine 
the relationships of dual-task measures to falls in individuals with HD. We hypothesized that 
individuals with HD would experience reductions in walking speed under dual-task conditions, 
and that impairments in dual-task walking would be linked with cognitive performance. We 
further hypothesized that dual-task assessment would be related to prospective falls.  
Methods 
Site and participant selection.  This study utilized baseline data from the Exercise Rehabilitation 
Trial in Huntington’s Disease (ExeRT-HD) trial[17] which was conducted across six HD 
specialist clinics in Europe:  Cardiff, Birmingham, and Oxford, UK; Leiden, Netherlands; 
Munster, Germany; and Oslo, Norway (trial registration ISRCTN11392629). The study was 
approved by the Wales Research Ethics Committee 2 (reference number 13/WA/0315).  
Inclusion and exclusion criteria.  Participants were eligible for the study if they met the following 
criteria, which were set forth for the intervention trial.  Inclusion criteria:  1) genetically 
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confirmed diagnosis of HD; 2) >18 years of age; 3) stable medication regime for four weeks 
prior to trial initiation, and 4) anticipated to maintain a stable regime for the course of trial.  
Exclusion criteria: 1) any physical or psychiatric condition that would prohibit the participant 
from completing the intervention or full battery of assessments, 2) inability to independently use 
an exercise bike, 3) unable to understand or communicate in spoken English (UK sites), 4) 
currently involved in any intervention trial or within four weeks of completing one, 5) current, 
regular participation in a structured exercise program five times per week or more.   
Recruitment.  Participants were recruited to the ExeRT-HD trial between March 2014 and 
January 2015; 32 individuals met the inclusion criteria[17] for the study. Written informed 
consent was taken for all participants.  
Assessors. Data collection was conducted by assessors at each site, who were specifically trained 
in the methodology utilized for collection of physical activity and functional assessments.  
Assessments 
Demographics.  We collected age and gender, and measured participant height and 
weight. Medication was recorded at baseline and is reported elsewhere[17].  
Disease-specific measures.  The UHDRS-TMS and Total Functional Capacity (TFC) 
were obtained from clinical records. UHDRS-TMS and TFC scores were conducted by certified 
ratersi within three months prior to the assessments.  
Cognitive Measures. Cognitive function was assessed using the following cognitive tests:  
1) Stroop color naming, word reading and interference tests[18], 2) Category Verbal Fluency 
Test (CVFT-Animals)[18],  3) Symbol Digit Modalities Test (SDMT)[18], and 4) Trail Making 
A and B[19]. This targeted cognitive battery has been optimized for HD[19] . 
                                                        
i
 Raters were certified by the European Huntington’s Disease Motor Rater certification 
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Dual-task measures.  We evaluated dual-task ability using the Walking While Talking 
Test (WWTT)[20].  During this test, a combination of motor and cognitive tasks were evaluated 
under simple and complex dual-task conditions.  Participants were first asked to cite the alphabet 
sitting and the time and number of errors were recorded.  The participants were then asked to 
walk for 20 ft out and back (40 ft total), and the time was recorded.ii  The participant was then 
asked to walk the same distance while reciting the alphabet (simple).  The time to complete the 
walk and the number of correct letters and number of errors was recorded.  Lastly, the participant 
was asked to walk the same distance again while reciting every other letter of the alphabet 
(complex).  The time to complete the walk and the number of correct letters and number of errors 
was recorded.  Appendix A provides further detailed information about the task instructions. 
Dual-task cost (DTC) quantifies the change in performance under dual-task conditions relative to 
the single task condition[21]. Gait and Cognitive DTCs were calculated following the methods of 
Hall et al[21].  DTCs were expressed as percentages to examine Dual-Task Effect[22]. 
Falls Assessment. Falls were assessed prospectively from the time of baseline assessment 
over a three-month period.  Falls were assessed using falls diaries, which were given to all 
participants at the end of the baseline assessment.  Participants were asked to record at the end of 
each week if they had any falls, and if yes, to describe the circumstances and any injuries 
sustained.   
Statistical Analyses. Statistical analyses were completed with Stata 11 (StataCorp, College 
Station TX) and SPSS Version 24 (IBM, Armonk NY). To examine relationships among dual-
task walking and motor, cognitive and disease-specific measures and falls, Spearman 
                                                        
ii The assessment was administered over a total distance of 20m rather than 40ft in 10 participants at one site.  This 
was noted during the second assessment of the eighth participant; the final three participants from this site (from 10 
total participants) were subsequently evaluated under both 20m and 40ft conditions, and this data was used to 
estimate a conversion to the 12.2m distance for all participants. 
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correlations were used; bootstrapping analysis was performed to calculate 95% confidence 
intervals. Using Mann-Whitney tests, we compared performance along the disease spectrum by 
dividing the group at the median UHDRS-TMS. Walking velocity was calculated from timed 
walking speed on the baseline condition of the WWTT. Finally, we completed a sub-analysis on 
individuals who returned prospective falls diaries to understand if dual-task measures are related 
to falls in HD.  
 
Results 
Individuals performed all testing in a single day in a standardized order. Demographic 
information is shown in Table 1. 
Dual-Task Performance.  Under dual-task conditions, gait speed declined significantly from 
baseline in both the simple (p=0.004) and complex (p=0.001) conditions. Figure 1 shows that the 
majority of individuals prioritized gait with a decline in cognition, or experienced mutual 
interference, with declines in both gait and cognitive performance.  
Relationship of Dual-Task Walking Time to Motor and Function Scores:  Time to complete the 
WWTT-simple was moderately correlated with UHDRS-TMS, but not age, gender, or TFC 
(Table 2; Figure 2A). Interestingly, the WWTT-complex was not related to UHDRS-TMS, but 
was strongly correlated with TFC, with faster times to complete the complex walking condition 
linked with higher TFC scores (i.e., higher independence) (Table 2). Gait and cognitive DTC 
measures were not related to motor or function scores (r<|0.22|; p>0.23).  
Relationship of Dual-Task Walking Time to Cognitive Performance:  Slower time to complete 
the WWTT-simple was moderately correlated with poorer performance on the Trail Making 
Test, Stroop word and interference, and SDMT (Table 3; Figure 2B). Similarly, slower time to 
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complete the WWTT-complex was moderately correlated with poorer performance on both 
Trails A and Trails B, as well as poorer performance on the color, word, and interference 
conditions of the Stroop and the SDMT (Table 3). Gait and cognitive DTC for the simple or 
complex conditions were not related to cognitive measures (r<|0.21|; p>0.26). 
Dual-Task Measurement May be Particularly Useful in Individuals with UHDRS-TMS <35.  To 
examine relationships of dual-task measures to cognition along the disease spectrum, we split the 
group by the median UHDRS-TMS score, 35, resulting in 16 individuals in each group. 
Comparisons between groups are shown in Table 1. 
In individuals with TMS<35, timed walking and WWTT-simple were related to Trails A 
(r=0.53; p=0.04; CI (-0.004 to 0.80) and r=0.70; p=0.003; CI (0.29 to 0.93), respectively) and B 
(r=0.55; p=0.03; CI (-0.16 to 0.82) and r=0.52; p=0.04; CI (-0.003 to 0.83), respectively) 
performance but no other measures of cognition. Similarly, timed walking and simple dual-task 
walking were correlated with gender (r=0.63; p=0.01; CI (0.06 to 0.87) and r=0.50; p=0.05; CI (-
0.11 to 0.84), respectively) but no other disease specific measures. Interestingly, WWTT-
complex performance was strongly correlated with TFC (r=-0.63; p=0.01; CI (-0.90 to -0.22)) as 
well as Trails A performance (r=0.54; p=0.03; CI (0.06 to 0.83)).  
In individuals with TMS≥35, none of the walking measures were related to demographic 
or disease-specific measures or to any of the cognitive measures.  
Relationship of Dual-Task Measures to Prospective Falls.  Nineteen individuals completed and 
returned the prospective falls diary (response rate =59%). The diaries indicated the number of 
falls that had occurred in the subsequent 3 months following baseline assessment. We completed 
a sub-analysis on these 19 subjects (mean (SD) age: 50.2(14.1); TMS: 35.6 (20.6); TFC: 8.1 
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(2.9); gender: 10M; 9F) to examine relationships among motor, cognitive and dual-task measures 
and prospective falls.  
Although the number of prospective falls was not related to timed walking (r=0.426; 
p=0.069; CI (-0.07 to 0.74)), they were strongly correlated to WWTT-simple (r=0.86; p<0.001; 
CI (0.62 to 0.96)), and moderately correlated with WWTT-complex (r=0.44; p=0.058; CI (0.01 
to 0.73)). This indicates that these measures of walking and dual-task walking may be useful 
clinical tools to predict future falls in individuals with HD.  
Interestingly, when we divided the fallers by UHDRS-TMS score, the prospective 
number of falls (n=10 reporters) in individuals with TMS<35 was not related to the walking 
measures; however, in individuals with TMS≥35 (n=9 reporters), prospective falls were strongly 
correlated with both walking (r=0.84; p=0.004; CI (0.56 to 0.95) and dual-task walking (r=0.85; 
p=0.004; CI (0.63 to 0.95) for simple and r=0.76; p=0.02; CI (0.23 to 0.96) for complex). 
 
Discussion 
This paper is the first to report the presence of cognitive-motor dual-task deficits in people 
with early-mid stage HD.  Our results suggest that individuals with HD have impairments in 
cognitive-motor dual-task ability that are related to disease progression and specifically global 
functional abilities. Dual-task measures appear to evaluate a unique construct in individuals with 
early to mid-stage HD, and dual-task measures may have value in improving the prediction of 
falls risk in this population.  
In this study, we evaluated both simple and complex dual-task during a walking while 
talking task. Task complexity was increased by adding an inhibitory speech component to the 
“complex” dual-task condition. Previous work has shown that performing a cognitive-motor 
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dual-task resulted in a greater deterioration of gait speed and parameters (including stride to 
stride variability) in patients with HD compared to healthy controls[13].  In our cohort, the 
decline in gait speed with dual-task performance was comparable to individuals with PD[23]. 
Furthermore, cognitive-motor dual-tasks have been shown to be more impaired compared to two 
motor tasks completed simultaneously[13]. In people with neurologic disease, previously 
automatic tasks may become attention demanding[24]; thus, tasks like walking or balance in 
standing may require greater cognitive resources. The cognitive reserve hypothesis theorizes that 
innate intelligence and level of education are related to progression of disease symptoms[25] and 
the brain’s capacity to cope with the neurodegenerative disease process[26]. Higher cognitive 
reserve has been associated with better cognitive performance and a significant slowing in 
cognitive decline in PD[27]. Figure 1 shows that most individuals with HD in our cohort 
experienced mutual interference, resulting in declines of both gait and cognitive performance 
under dual-task conditions. Importantly, many subjects prioritized gait ability; as walking 
becomes more cognitively demanding, individuals with HD may choose to attend to walking 
ability, leaving fewer cognitive resources for other tasks. 
An interesting finding in this study was the differing relationship of simple and complex 
dual-tasks to UHDRS-TMS and TFC scores. Simple dual-task was associated with UHDRS-
TMS, but not TFC while complex dual-task was strongly related to TFC but not to UHDRS-
TMS.  The simple dual-task, which required participants to walk at a comfortable pace while 
saying the alphabet, may have placed more emphasis on the motor component (walking), as 
reciting the alphabet may not have been particularly demanding from a resource allocation 
perspective.  The complex nature of saying every other letter, however, clearly pushed 
participant’s cognitive abilities, and thus is more related to the TFC score; a general measure of 
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function incorporating cognitive and motor abilities. The TFC is often used as an indication of 
overall independent functioning; thus, assessment of complex dual-tasks may aid clinicians in 
determining daily function of an individual and could cue necessary referrals for rehabilitation. 
Dual-task function represents a unique construct that may be particularly important in a 
complex, neurodegenerative disease such as HD, in which cognitive and motor impairments are 
hallmarks of the disease from an early stage. With the ever-increasing number of pharmacologic 
and other clinical trials aimed at slowing disease progression, there is an urgent need for clinical 
end points that can readily be used in clinical settings and across disease stages.  While motor 
evaluations, such as the UHDRS-TMS, and cognitive measures, including Trails A, may be 
sensitive measures of disease progression[28], dual-task may measure a unique construct that 
encompasses both cognitive and motor impairments from an early stage. Recent work by 
Vaportzis et al.[8] suggests that dual-task measures may be a better measure of cognitive 
processing in HD, and that impaired automaticity may be responsible for these impairments. The 
main site of early pathology in HD is the striatum, which may play a role in dual-information 
processing[8].  The basal ganglia have been shown to be active during implementation of learned 
motor programs[29], which may lend support to clinical observations of loss of automaticity in 
HD[9].   
Dual-task measures may be particularly useful for identifying cognitive decline in 
patients in early stages of the disease. For participants with UHDRS-TMS<35, WWTT-simple 
were related to Trails A and B performance, while WWTT-complex performance was 
significantly related to both TFC and Trails A performance. In individuals with UHDRS-
TMS<35, prospective falls were not related to walking measures; however, dual-task measures 
may be indicative of fall risk in individuals with UHDRS-TMS≥35. For this group, dual-task 
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walking measures were not related to cognitive or disease-specific measures, but prospective 
falls were strongly related to dual-task walking. This suggests that dual-task measures may have 
differential usefulness across the spectrum of motor severity. Larger sample sizes are necessary 
to confirm this hypothesis. 
Gait speed has been shown to be sensitive to disease progression in HD[30], however its 
relationship to balance and falls risk in this population has not been established. In this study,  
ability to perform another task while walking was related to reported falls. Fall prediction in 
neurodegenerative diseases has proved challenging, likely due to the many impairment and 
environmental factors that contribute to falls. Dual-task measures incorporate motor and 
cognitive functioning in a unique way that challenges individuals with HD and may be useful for 
clinicians examining fall risk in HD.  
While dual-task measures may be useful assessment tools to probe cognitive function or 
fall risk in HD, little is known about how individuals with HD may respond to targeted dual-task 
training. Specific motor-cognitive dual-task interventions have been undertaken in many 
neurologic populations with overall success at improving dual-task ability in walking. In one 
study[31], individuals with HD participated in a video-game based training program requiring 
participants to step to targets in response to cues on a screen, thereby incorporating both motor 
and cognitive components. Kloos et al. found that individuals with less severe motor impairment 
responded better to this intervention than those with more severe impairments[31]. This suggests 
that specific interventions aimed at addressing dual-task problems should be the focus of 
rehabilitation interventions from the early stages of HD.   
While this study is the first to report the presence of dual-task impairments and their 
relation to falls in HD, this was a relatively small sample size and should be repeated in a larger 
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patient population.  A more representative group of patients across the disease spectrum would 
be necessary to determine if cognitive-motor dual-task measures will be a sensitive marker of 
disease progression. Prospective falls information corroborated by carers would strengthen the 
findings, as maintaining fall diaries can be challenging for individuals with HD. Future work 
should consider the effect of task type and complexity of dual task ability. In addition, future 
studies are required to more fully elucidate factors contributing to falls risk in this population, 
including both dual-task measures and a more comprehensive assessment of balance and 
coordination.  
Conclusions 
 Individuals with HD experience dual-task deficits related to disease progression and 
global functional ability. Dual-task measures a unique construct in HD and has the potential to 
improve fall prediction. Future studies should examine the utility of dual-task measures as 
clinical endpoints and explore interventions to improve dual-task performance in HD.  
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Table 1. Demographics and performance on functional and disease-specific measures in all 
subjects and when subdivided by UHDRS-TMS score. 
 HD 
(n= 32) 
UHDRS-
TMS<35  
(n=16) 
UHDRS-TMS ≥35 
(n=16) 
Age (years) 52.0 (14.0) 45.6 (14.2) 58.4 (10.7)* 
Gender (M:F) 16:16 5:11 11:5 
TFC 8.4 (2.9) 9.1 (2.4) 7.8 (3.2) 
UHDRS-TMS 35.8 (19.0) 20.6 (8.0) 51.1 (13.6)** 
SDMT 
# correct 
 
25.3 (9.9) 
 
29.3 (9.3) 
 
21.3 (9.2)* 
Stroop 
# correct 
Word 
Color 
Interference 
 
 
60.0 (18.2) 
44.1 (14.6) 
24.5 (8.9) 
 
 
65.8 (14.5) 
48.1 (14.0) 
29.1 (7.5) 
 
 
54.1 (20.1) 
40.1 (14.4) 
20.9 (8.5)* 
Trail Making Test (s) 
A 
B 
 
69.4 (47.2) 
143.1 (67.0) 
 
56.2 (30.7) 
124.2 (69.0) 
 
82.5 (57.3) 
164.6 (59.8) 
CVFT 
#correct 
 
15.1 (5.4) 
 
17.1 (4.8) 
 
13.1 (5.3) 
WWTT 
Timed Walking (s) 
Simple (s) 
Complex (s) 
Gait DTC Simple 
Gait DTC Complex 
Cognitive DTC Simple 
 
11.9 (4.1) 
13.4 (5.6) 
19.5 (14.0) 
0.13 (0.19) 
0.61 (0.65) 
-0.04 (0.46) 
 
 
10.5 (2.5) 
11.9 (3.3) 
17.1 (8.5) 
0.14 (0.18) 
0.63 (0.55) 
-0.037 (0.44) 
 
13.3 (4.9) 
14.9 (7.0) 
21.9 (17.9) 
0.12 (0.21) 
0.59 (0.75) 
-0.045 (0.49) 
Calculated Walking Speed at 
Baseline (m/s) 
 
1.13 (0.33) 
 
1.23 (0.079) 
 
1.03 (0.085) 
All values are shown mean (SD). * Indicates that the TMS≥35 was significantly different from 
the TMS<35 group at p<0.05 or **p<0.01. 
Total Functional Composite (TFC); United Huntington’s Disease Rating Scale-Total Motor 
Score (UHDRS-TMS); Symbol Digit Modalities Test (SDMT); Category Verbal Fluency Test 
(CVFT); Walking While Talking Test (WWTT); Dual-Task Cost (DTC). 
  
15 
 
Table 2. Relationship of Walking Measures to UHDRS-TMS and TFC Scores.  
  Spearman’s Rho 95% Confidence 
Interval 
Baseline Walking  UHDRS-TMS 
TFC 
0.397* 
-0.281 
-0.015 to 0.670 
-0.594 to 0.095 
Calculated Walking Speed UHDRS-TMS 
TFC 
-0.395* 
0.281 
-0.676 to -0.009 
-0.087 to 0.593 
WWTT-Simple UHDRS-TMS 
TFC 
0.374* 
-0.287 
-0.006 to 0.661 
-0.625 to 0.082 
WWTT-Complex UHDRS-TMS 
TFC 
0.310 
-0.618** 
-0.057 to 0.606 
-0.832 to -0.321 
* p<0.05; **p<0.01. Total Functional Composite (TFC); United Huntington’s Disease Rating 
Scale-Total Motor Score (UHDRS-TMS); Walking While Talking Test (WWTT). 
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Table 3. Relationship of Walking Measures to Cognitive Performance. 
  Spearman’s Rho 95% Confidence 
Interval 
Baseline Walking Trails A 
Trails B 
Stroop Color 
Stroop Word 
Stroop Interference 
SDMT 
0.401* 
0.396* 
-0.261 
-0.412* 
-0.415* 
-0.447* 
-0.053 to 0.725 
0.038 to 0.704 
-0.623 to 0.134 
-0.751 to 0.084 
-0.686 to 0.027 
-0.737 to -0.024 
Calculated Walking 
Speed 
Trails A 
Trails B 
Stroop Color 
Stroop Word 
Stroop Interference 
SDMT 
-0.420* 
-0.396* 
0.261 
0.377* 
0.396* 
0.447* 
-0.665 to -0.014 
-0.692 to -0.026 
-0.193 to 0.619 
-0.097 to 0.736 
-0.122 to 0.734 
-0.009 to 0.763 
WWTT-Simple Trails A 
Trails B 
Stroop Color 
Stroop Word 
Stroop Interference 
SDMT 
0.520* 
0.418* 
-0.337 
-0.419* 
-0.510** 
-0.432* 
0.050 to 0.750 
0.007 to 0.735 
-0.665 to 0.076 
-0.694 to -0.013 
-0.760 to -0.124 
-0.728 to 0.007 
WWTT-Complex Trails A 
Trails B 
Stroop Color 
Stroop Word 
Stroop Interference 
SDMT 
0.527** 
0.510** 
-0.372* 
-0.353* 
-0.377* 
-0.499** 
0.158 to 0.745 
0.131 to 0.787 
-0.694 to 0.106 
-0.694 to 0.093 
-0.648 to 0.057 
-0.730 to -0.122 
* p<0.05; **p<0.01. Symbol Digit Modalities Test (SDMT); Walking While Talking Test 
(WWTT). 
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Figure 1. An examination of the dual-task effects of the cognitive and gait conditions[22] on the 
WWTT-simple reveals that the majority of individuals with HD in this cohort either experienced 
mutual interference, where both gait and cognitive performance declined under dual-task 
conditions, or prioritized gait, such that gait speed increased but cognitive performance 
decreased under dual-task conditions. The dual-task effect is the calculated percent difference 
between performance in the single task and performance in the dual-task.  This was calculated 
for both the gait and cognitive conditions and this is shown on the y- and x-axis, respectively. 
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Figure 2. WWTT-Simple is associated with A) UHDRS-TMS (r=0.3737; p=0.0351) and B) 
SDMT performance (r=-0.4322; p=0.0152), suggesting that that dual-task assessment measures a 
unique construct that is highly related to both functional and cognitive performance in 
individuals with HD. 
 
 
22 
 
Appendix A: Standard Operating Procedures for Administration of Dual-Task Testing 
 
Timed Gait 
Task:  Participant should be instructed to walk 20ft (6.1m) to the marker turn around and return 
back to the starting point (40 ft in total) at their own normal walking pace. 
 
Instructions: “I want you to walk at your normal pace around this cone and turn and come back 
to here.  Ready?  Go.” 
Scoring: Score the time to complete test to nearest 10th of a second 
 
Cognitive seated task 
Task: Time how long it takes the participant to complete reciting the alphabet from A-Z while 
seated.  
 
Instructions:  “I want you to recite the alphabet from A-Z, pronouncing each letter.  Ready?  
GO” 
 
Scoring: Follow the tick boxes in the data collection form as they recite the letters out loud, 
marking any incorrect with a ‘X’. Record number correct, number of errors and time to complete 
the task. 
 
Walking while talking - simple 
Task:  Instruct the participant to walk 20ft (6.1m) to the marker turn around and return back to 
the starting point (40 ft in total) at their own normal walking pace, this time reciting the alphabet 
as they are walking.  
 
Instructions:  “I want you to walk at your normal pace around this cone and turn and come back 
to here.  While you are doing this, recite the alphabet starting with the letter A, pronouncing each 
letter.  Ready?  GO” 
 
Scoring:  Record if any mistakes are made and the time taken to complete the distance. 
 
Walking while talking - complex:  
Task:  Instruct the participant to walk 20ft (6.1m) to the marker turn around and return back to 
the starting point (40 ft in total) at their own normal walking pace, this time reciting every other 
letter of the alphabet as they are walking, starting with ‘A’. 
 
Instructions:  “I want you to walk at your normal pace around this cone and turn and come back 
to here.  While you are doing this, recite EVERY OTHER letter of the alphabet starting with the 
letter A, pronouncing each letter.  Ready?  GO” 
 
Scoring:  Record if any mistakes are made and the time taken to complete the distance. 
 
 
 
